Paul G. Richardson, MD | Authors


Melflufen Plus Dexamethasone Safe and Effective For R/R Multiple Myeloma

September 15, 2019

Paul G. Richardson, MD, clinical program leader and director of clinical research of the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute and RJ Corman Professor of Medicine, Harvard School of Medicine, discusses the interesting safety and efficacy profiles of the HORIZON trial.